Category:Videos of diseases and disorders of the nervous system

| Radiology: Ultrasound · X-ray · Computed tomography · Magnetic resonance · Positron emission tomography | Anatomical pathology: Cytopathology · Gross pathology · Histopathology | Other: Epidemiology (Map → World) | File format: Audio · SVG · Video recording |

Subcategories

This category has the following 6 subcategories, out of 6 total.

*

Videos of peripheral nervous system disorders‎ (1 C, 3 F)

B

Videos of brachial plexus neuropathies‎ (2 F)

C

Videos of diseases and disorders of the central nervous system‎ (9 C, 4 F)

N

Videos of nervous system neoplasms‎ (3 C, 6 F)
Videos of neurodegenerative diseases and disorders‎ (4 C, 108 F)

T

Videos of tumors of the nervous system‎ (3 C, 1 F)

Media in category "Videos of diseases and disorders of the nervous system"

The following 80 files are in this category, out of 80 total.

A-Computational-Framework-for-Ultrastructural-Mapping-of-Neural-Circuitry-pbio.1000074.sv001.ogv 9.0 s, 800 × 800; 5.45 MB
A-Computational-Framework-for-Ultrastructural-Mapping-of-Neural-Circuitry-pbio.1000074.sv002.ogv 19 s, 600 × 322; 2.22 MB
A-Computational-Framework-for-Ultrastructural-Mapping-of-Neural-Circuitry-pbio.1000074.sv003.ogv 34 s, 466 × 500; 27.98 MB
A-Helical-Structural-Nucleus-Is-the-Primary-Elongating-Unit-of-Insulin-Amyloid-Fibrils-pbio.0050134.sv001.ogv 1 min 0 s, 320 × 240; 2.68 MB
A-Helical-Structural-Nucleus-Is-the-Primary-Elongating-Unit-of-Insulin-Amyloid-Fibrils-pbio.0050134.sv002.ogv 0.0 s, 240 × 240; 3.1 MB
Amplitude-of-the-SCN-Clock-Enhanced-by-the-Behavioral-Activity-Rhythm-pone.0039693.s003.ogv 1 min 1 s, 640 × 480; 1.29 MB
Amplitude-of-the-SCN-Clock-Enhanced-by-the-Behavioral-Activity-Rhythm-pone.0039693.s004.ogv 59 s, 640 × 480; 1.21 MB
CA8-Mutations-Cause-a-Novel-Syndrome-Characterized-by-Ataxia-and-Mild-Mental-Retardation-with-pgen.1000487.s001.ogv 1 min 2 s, 320 × 240; 3.69 MB
Cholinergic-Modulation-of-Narcoleptic-Attacks-in-Double-Orexin-Receptor-Knockout-Mice-pone.0018697.s001.ogv 56 s, 352 × 240; 1.2 MB
Cholinergic-Modulation-of-Narcoleptic-Attacks-in-Double-Orexin-Receptor-Knockout-Mice-pone.0018697.s002.ogv 1 min 49 s, 352 × 240; 2.2 MB
Cholinergic-Modulation-of-Narcoleptic-Attacks-in-Double-Orexin-Receptor-Knockout-Mice-pone.0018697.s003.ogv 58 s, 352 × 240; 1.05 MB
Cholinergic-Modulation-of-Narcoleptic-Attacks-in-Double-Orexin-Receptor-Knockout-Mice-pone.0018697.s004.ogv 52 s, 352 × 240; 1.7 MB
Cpd-1-Null-Mice-Display-a-Subtle-Neurological-Phenotype-pone.0012649.s004.ogv 12 s, 720 × 480; 3.86 MB
Cpd-1-Null-Mice-Display-a-Subtle-Neurological-Phenotype-pone.0012649.s005.ogv 15 s, 720 × 480; 5.74 MB
Effect-of-Rhythmic-Auditory-Stimulation-on-Gait-in-Parkinsonian-Patients-with-and-without-Freezing-pone.0009675.s001.ogv 43 s, 375 × 288; 1.1 MB
Effect-of-Rhythmic-Auditory-Stimulation-on-Gait-in-Parkinsonian-Patients-with-and-without-Freezing-pone.0009675.s002.ogv 15 s, 375 × 288; 538 KB
Effect-of-Rhythmic-Auditory-Stimulation-on-Gait-in-Parkinsonian-Patients-with-and-without-Freezing-pone.0009675.s003.ogv 53 s, 375 × 288; 1.36 MB
Effect-of-Rhythmic-Auditory-Stimulation-on-Gait-in-Parkinsonian-Patients-with-and-without-Freezing-pone.0009675.s004.ogv 33 s, 375 × 288; 972 KB
Evidence-for-the-Re-Enactment-of-a-Recently-Learned-Behavior-during-Sleepwalking-pone.0018056.s003.ogv 1 min 0 s, 768 × 576; 2.42 MB
Experimental-and-Computational-Analysis-of-Polyglutamine-Mediated-Cytotoxicity-pcbi.1000944.s004.ogv 14 s, 694 × 520; 3.95 MB
Experimental-and-Computational-Analysis-of-Polyglutamine-Mediated-Cytotoxicity-pcbi.1000944.s005.ogv 14 s, 694 × 520; 793 KB
Experimental-and-Computational-Analysis-of-Polyglutamine-Mediated-Cytotoxicity-pcbi.1000944.s006.ogv 14 s, 694 × 520; 5.08 MB
Experimental-and-Computational-Analysis-of-Polyglutamine-Mediated-Cytotoxicity-pcbi.1000944.s007.ogv 14 s, 694 × 520; 666 KB
Experimental-and-Computational-Analysis-of-Polyglutamine-Mediated-Cytotoxicity-pcbi.1000944.s008.ogv 14 s, 694 × 520; 5.87 MB
Experimental-and-Computational-Analysis-of-Polyglutamine-Mediated-Cytotoxicity-pcbi.1000944.s009.ogv 14 s, 694 × 520; 818 KB
Experimental-and-Computational-Analysis-of-Polyglutamine-Mediated-Cytotoxicity-pcbi.1000944.s010.ogv 14 s, 694 × 520; 4.67 MB
Experimental-and-Computational-Analysis-of-Polyglutamine-Mediated-Cytotoxicity-pcbi.1000944.s011.ogv 14 s, 694 × 520; 340 KB
Free-functional-gracilis-muscle-transfer-in-children-with-severe-sequelae-from-obstetric-brachial-1749-7221-3-23-S1.ogv 5.0 s, 160 × 112; 93 KB
Free-functional-gracilis-muscle-transfer-in-children-with-severe-sequelae-from-obstetric-brachial-1749-7221-3-23-S2.ogv 5.0 s, 160 × 112; 80 KB
Genetic-Modifiers-of-MeCP2-Function-in-Drosophila-pgen.1000179.s006.ogv 50 s, 384 × 288; 1,008 KB
Mechanisms-Underlying-Metabolic-and-Neural-Defects-in-Zebrafish-and-Human-Multiple-Acyl-CoA-pone.0008329.s013.ogv 27 s, 247 × 242; 191 KB
Mechanisms-Underlying-Metabolic-and-Neural-Defects-in-Zebrafish-and-Human-Multiple-Acyl-CoA-pone.0008329.s014.ogv 27 s, 247 × 242; 240 KB
Membrane-Permeabilization-by-Oligomeric-α-Synuclein-In-Search-of-the-Mechanism-pone.0014292.s001.ogv 8.6 s, 512 × 512; 1.33 MB
Mice-Doubly-Deficient-in-Lysosomal-Hexosaminidase-A-and-Neuraminidase-4-Show-Epileptic-Crises-and-pgen.1001118.s015.ogv 12 s, 640 × 480; 2.02 MB
Motor-tics-evoked-by-striatal-disinhibition-in-the-rat-Movie1.ogv 37 s, 768 × 576; 10.77 MB
Mutant-Glycyl-tRNA-Synthetase-(Gars)-Ameliorates-SOD1G93A-Motor-Neuron-Degeneration-Phenotype-but-pone.0006218.s008.ogv 27 s, 768 × 576; 1.42 MB
Mutant-Glycyl-tRNA-Synthetase-(Gars)-Ameliorates-SOD1G93A-Motor-Neuron-Degeneration-Phenotype-but-pone.0006218.s009.ogv 1 min 0 s, 768 × 576; 3 MB
Mutant-Glycyl-tRNA-Synthetase-(Gars)-Ameliorates-SOD1G93A-Motor-Neuron-Degeneration-Phenotype-but-pone.0006218.s010.ogv 59 s, 768 × 576; 2.5 MB
Mutant-Glycyl-tRNA-Synthetase-(Gars)-Ameliorates-SOD1G93A-Motor-Neuron-Degeneration-Phenotype-but-pone.0006218.s011.ogv 1 min 0 s, 768 × 576; 3.15 MB
Ophthalmoplegia-and-Slurred-Speech-in-an-Intravenous-Drug-User-pmed-0030453-sv001.ogv 2 min 43 s, 440 × 360; 19.97 MB
Polyglutamine-Expansion-Accelerates-the-Dynamics-of-Ataxin-1-and-Does-Not-Result-in-Aggregate-pone.0001503.s001.ogv 27 s, 212 × 187; 779 KB
Posttranslational-Modifications-Localization-and-Protein-Interactions-of-Optineurin-the-Product-of-pone.0009168.s002.ogv 3.0 s, 194 × 147; 15 KB
Posttranslational-Modifications-Localization-and-Protein-Interactions-of-Optineurin-the-Product-of-pone.0009168.s003.ogv 2.0 s, 278 × 264; 96 KB
Protection-by-the-NDI1-Gene-against-Neurodegeneration-in-a-Rotenone-Rat-Model-of-Parkinson's-Disease-pone.0001433.s003.ogv 15 s, 752 × 560; 2.64 MB
Protection-by-the-NDI1-Gene-against-Neurodegeneration-in-a-Rotenone-Rat-Model-of-Parkinson's-Disease-pone.0001433.s004.ogv 1 min 13 s, 176 × 144; 394 KB
Regulation-of-Embryonic-Cell-Adhesion-by-the-Prion-Protein-pbio.1000055.sv001.ogv 8.0 s, 299 × 299; 1.19 MB
Regulation-of-Embryonic-Cell-Adhesion-by-the-Prion-Protein-pbio.1000055.sv002.ogv 8.0 s, 356 × 357; 1.66 MB
Regulation-of-Embryonic-Cell-Adhesion-by-the-Prion-Protein-pbio.1000055.sv003.ogv 12 s, 158 × 155; 88 KB
Regulation-of-Embryonic-Cell-Adhesion-by-the-Prion-Protein-pbio.1000055.sv004.ogv 12 s, 158 × 156; 92 KB
Regulation-of-Embryonic-Cell-Adhesion-by-the-Prion-Protein-pbio.1000055.sv005.ogv 2.1 s, 1,024 × 1,024; 1.68 MB
Regulation-of-Embryonic-Cell-Adhesion-by-the-Prion-Protein-pbio.1000055.sv006.ogv 12 s, 523 × 512; 340 KB
Responses-to-Environmental-Enrichment-Differ-with-Sex-and-Genotype-in-a-Transgenic-Mouse-Model-of-pone.0009077.s002.ogv 30 s, 524 × 384; 5.35 MB
Responses-to-Environmental-Enrichment-Differ-with-Sex-and-Genotype-in-a-Transgenic-Mouse-Model-of-pone.0009077.s003.ogv 15 s, 524 × 384; 1.01 MB
Sleep-Related-Declarative-Memory-Consolidation-and-Verbal-Replay-during-Sleep-Talking-in-Patients-pone.0083352.s004.ogv 57 s, 640 × 640; 1.97 MB
Surgical-fasciectomy-of-the-trapezius-muscle-combined-with-neurolysis-of-the-Spinal-accessory-nerve-1749-7221-5-7-S1.ogv 5.5 s, 960 × 720; 2.75 MB
Surgical-fasciectomy-of-the-trapezius-muscle-combined-with-neurolysis-of-the-Spinal-accessory-nerve-1749-7221-5-7-S3.ogv 3.0 s, 960 × 720; 771 KB
Systematic-In-Vivo-Analysis-of-the-Intrinsic-Determinants-of-Amyloid-β-Pathogenicity-pbio.0050290.sv001.ogv 15 s, 320 × 240; 363 KB
Systematic-In-Vivo-Analysis-of-the-Intrinsic-Determinants-of-Amyloid-β-Pathogenicity-pbio.0050290.sv002.ogv 19 s, 320 × 240; 566 KB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S1.ogv 14 s, 320 × 240; 724 KB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S10.ogv 56 s, 320 × 240; 2.64 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S11.ogv 1 min 37 s, 320 × 240; 2.89 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S12.ogv 1 min 7 s, 320 × 240; 1.62 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S13.ogv 46 s, 320 × 240; 1.37 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S14.ogv 59 s, 320 × 240; 2.03 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S15.ogv 46 s, 320 × 240; 1.72 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S16.ogv 27 s, 320 × 240; 1.27 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S2.ogv 16 s, 320 × 240; 618 KB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S3.ogv 1 min 7 s, 320 × 240; 2.7 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S4.ogv 36 s, 320 × 240; 1.5 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S5.ogv 58 s, 320 × 240; 2.45 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S6.ogv 47 s, 320 × 240; 1.61 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S7.ogv 51 s, 320 × 240; 2.12 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S8.ogv 33 s, 320 × 240; 1.78 MB
The-Motor-Function-Neurological-Assessment-(MFNU)-as-an-indicator-of-motor-function-problems-in-1744-9081-5-22-S9.ogv 46 s, 320 × 240; 2.35 MB
The-Role-of-Myelin-in-Theiler's-Virus-Persistence-in-the-Central-Nervous-System-ppat.0030023.sv001.ogv 23 s, 1,498 × 854; 2.89 MB
The-Role-of-Myelin-in-Theiler's-Virus-Persistence-in-the-Central-Nervous-System-ppat.0030023.sv002.ogv 23 s, 1,498 × 854; 6.64 MB
The-Role-of-Myelin-in-Theiler's-Virus-Persistence-in-the-Central-Nervous-System-ppat.0030023.sv003.ogv 3.0 s, 1,386 × 1,030; 4.28 MB
The-Role-of-Myelin-in-Theiler's-Virus-Persistence-in-the-Central-Nervous-System-ppat.0030023.sv004.ogv 3.2 s, 606 × 552; 1.37 MB
The-Role-of-Myelin-in-Theiler's-Virus-Persistence-in-the-Central-Nervous-System-ppat.0030023.sv005.ogv 2.4 s, 1,385 × 1,030; 1.85 MB
The-Role-of-Myelin-in-Theiler's-Virus-Persistence-in-the-Central-Nervous-System-ppat.0030023.sv006.ogv 1.6 s, 1,300 × 1,030; 974 KB

Retrieved from "https://commons.wikimedia.org/w/index.php?title=Category:Videos_of_diseases_and_disorders_of_the_nervous_system&oldid=353684748"